Nanomedicines Working Group: Summary of liposomal survey and terminology poster
11 September 2017
Liposomal survey - results
The IPRF Nanomedicines Working Group (IPRF NWG) has identified the need to map and exchange requirements for nano drug product specific guidance. It was initially decided to focus on liposomal products as guidance documents from various jurisdictions are readily available. A survey was conducted of the Working Group’s members in 2016 with the summary presented here.
This study maps, compiles and discusses the currently used terminology and definitions in the regulatory landscape to address the lack of a shared terminology in the nanomedicine field among authorities, health care professionals and scientific experts.